SCHEMBL4140908

SCHEMBL4140908

CCCCCCCCCCCCC/C=C/C(O)C(CO)NC(=O)C(O)CCCCCCCCCCCCCC

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.71
CYP2D6 P10635 3/20 0.71
MAPK1 P28482 3/20 0.71
TP53 P04637 2/20 0.71
CYP1A2 P05177 2/20 0.71
CYP2C9 P11712 2/20 0.71
CYP2C19 P33261 2/20 0.71
CETP P11597 7/20 0.68
MEN1 O00255 4/20 0.68
KMT2A Q03164 4/20 0.68
THRB P10828 3/20 0.68
ASAH1 Q13510 2/20 0.67
ASAH2 Q9NR71 2/20 0.65
ALDH1A1 P00352 2/20 0.59
KDM4E B2RXH2 1/20 0.59
SPHK2 Q9NRA0 3/20 0.50
SPHK1 Q9NYA1 3/20 0.50
GMNN O75496 2/20 0.50
LMNA P02545 2/20 0.50
GLA P06280 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12795857 1.00 MAPT (0.71) MAPTCYP2D6MAPK1TP53CYP1A2
SCHEMBL31003583 1.00 MAPT (0.71) MAPTCYP2D6MAPK1TP53CYP1A2
SCHEMBL10001355 1.00 MAPT (0.71) MAPTCYP2D6MAPK1TP53CYP1A2
SCHEMBL4169155 1.00 MAPT (0.71) MAPTCYP2D6MAPK1TP53CYP1A2
SCHEMBL6661598 1.00 MAPT (0.71) MAPTCYP2D6MAPK1TP53CYP1A2
SCHEMBL12994189 1.00 MAPT (0.71) MAPTCYP2D6MAPK1TP53CYP1A2
SCHEMBL1976275 1.00 MAPT (0.71) MAPTCYP2D6MAPK1TP53CYP1A2
SCHEMBL12316166 1.00 MAPT (0.71) MAPTCYP2D6MAPK1TP53CYP1A2
SCHEMBL4133159 1.00 MAPT (0.71) MAPTCYP2D6MAPK1TP53CYP1A2
SCHEMBL30652483 1.00 MAPT (0.71) MAPTCYP2D6MAPK1TP53CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230372207-A1 CARBONATED AEROSOL EXTERNAL PREPARATION FOR SKIN KAO CORPORATION (JP) 2023-11-23 US disclosed
US-20230372207-A1 CARBONATED AEROSOL EXTERNAL PREPARATION FOR SKIN KAO CORPORATION (JP) 2023-11-23 US disclosed
US-20230240948-A1 METHOD FOR PRODUCING COATING KAO CORPORATION (JP) 2023-08-03 US disclosed
US-20230240948-A1 METHOD FOR PRODUCING COATING KAO CORPORATION (JP) 2023-08-03 US disclosed
US-20220031582-A1 OIL-IN-WATER TYPE SUNSCREEN COSMETIC KAO CORPORATION (JP) 2022-02-03 US disclosed
US-11166899-B2 Composition for external application containing a ceramide, a derivative thereof and an extract of Hibisci cortex AMOREPACIFIC CORPORATION (KR) 2021-11-09 US disclosed
WO-2020250966-A1 EMULSION COMPOSITION 花王株式会社 2020-12-17 WO disclosed
EP-3733160-A1 EMULSIFIED COMPOSITION Kao Corporation (JP) 2020-11-04 EP disclosed
US-20200337953-A1 EMULSIFIED COMPOSITION KAO CORPORATION (JP) 2020-10-29 US disclosed
US-20200179260-A1 COMPOSITION FOR EXTERNAL APPLICATION CONTAINING A CERAMIDE, A DERIVATIVE THEREOF AND AN EXTRACT OF HIBISCI CORTEX AMOREPACIFIC CORPORATION (KR) 2020-06-11 US disclosed
US-20090137453-A1 COMPOSITION COMPRISING AT LEAST ONE OXAZOLINE TO INHIBIT MIGRATION OF LANGERHANS CELLS, AND USES THEREOF MSIKA PHILIPPE 2009-05-28 US disclosed
US-20090137453-A1 COMPOSITION COMPRISING AT LEAST ONE OXAZOLINE TO INHIBIT MIGRATION OF LANGERHANS CELLS, AND USES THEREOF MSIKA PHILIPPE 2009-05-28 US disclosed
US-7511010-B2 Pharmaceutical or cosmetic composition and use of a PKC inhibitor with an MMP inhibitor for inhibiting Langerhans' cell migration LABORATOIRES EXPANSCIENCE (FR) 2009-03-31 US disclosed
US-7511010-B2 Pharmaceutical or cosmetic composition and use of a PKC inhibitor with an MMP inhibitor for inhibiting Langerhans' cell migration LABORATOIRES EXPANSCIENCE (FR) 2009-03-31 US disclosed
US-20090081148-A1 PROTECTION OF KERATINOUS FIBERS USING CERAMIDES AND/OR GLYCOCERAMIDES L'OREAL S.A. 2009-03-26 US disclosed
US-20090081148-A1 PROTECTION OF KERATINOUS FIBERS USING CERAMIDES AND/OR GLYCOCERAMIDES L'OREAL S.A. 2009-03-26 US disclosed
US-20090047231-A1 AQUEOUS HAIR COSMETIC COMPOSITION KAO CORPORATION (JP) 2009-02-19 US disclosed
US-20090047231-A1 AQUEOUS HAIR COSMETIC COMPOSITION KAO CORPORATION (JP) 2009-02-19 US disclosed
US-20080299063-A1 HAIR COSMETIC COMPOSITION KAO CORPORATION (JP) 2008-12-04 US disclosed
US-20080299063-A1 HAIR COSMETIC COMPOSITION KAO CORPORATION (JP) 2008-12-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137453-A1 COMPOSITION COMPRISING AT LEAST ONE OXAZOLINE TO INHIBIT MIGRATION OF LANGERHANS CELLS, AND USES THEREOF ARG1, MIF, ZAP70 MAPT 4534/4885CYP2D6 4257/4885MAPK1 332/4885
US-11166899-B2 Composition for external application containing a ceramide, a derivative thereof and an extract of Hibisci cortex CERT1, CERS2, SGMS1 MAPT 1201/4885CYP2D6 4756/4885MAPK1 3503/4885
US-20220031582-A1 OIL-IN-WATER TYPE SUNSCREEN COSMETIC SUN2, H1-0, CUTA MAPT 1522/4885CYP2D6 3044/4885MAPK1 2943/4885
US-20080299063-A1 HAIR COSMETIC COMPOSITION H1-0, H1-3, H1-2 MAPT 4266/4885CYP2D6 1532/4885MAPK1 688/4885
US-20230240948-A1 METHOD FOR PRODUCING COATING CUTA, KRT18, S100B MAPT 473/4885CYP2D6 2978/4885MAPK1 2247/4885
US-20090081148-A1 PROTECTION OF KERATINOUS FIBERS USING CERAMIDES AND/OR GLYCOCERAMIDES KRT18, CERT1, CERS2 MAPT 1108/4885CYP2D6 4841/4885MAPK1 2356/4885
US-20090047231-A1 AQUEOUS HAIR COSMETIC COMPOSITION POLR1C, CUTA, POLH MAPT 1450/4885CYP2D6 3984/4885MAPK1 3172/4885
US-20230372207-A1 CARBONATED AEROSOL EXTERNAL PREPARATION FOR SKIN CERT1, CERS2, SGMS2 MAPT 1954/4885CYP2D6 4725/4885MAPK1 4127/4885
US-20200337953-A1 EMULSIFIED COMPOSITION SGMS2, SGMS1, CERT1 MAPT 1501/4885CYP2D6 4300/4885MAPK1 4559/4885
US-20200179260-A1 COMPOSITION FOR EXTERNAL APPLICATION CONTAINING A CERAMIDE, A DERIVATIVE THEREOF AND AN EXTRACT OF HIBISCI CORTEX CERT1, CERS2, SGMS1 MAPT 1201/4885CYP2D6 4756/4885MAPK1 3503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.